# Sientra Post-Approval Study

> **NCT01639053** · — · UNKNOWN · sponsor: **Tiger Biosciences, LLC.** · enrollment: 5498 (actual)

## Conditions studied

- Breast Augmentation
- Breast Reconstruction
- Breast Revision

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01639053
- **Lead sponsor:** Tiger Biosciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 5498 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639053, "Sientra Post-Approval Study". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT01639053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*